Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 13, 2019

SELL
$28.91 - $50.0 $127,290 - $220,150
-4,403 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$30.85 - $50.65 $261,114 - $428,701
-8,464 Reduced 65.78%
4,403 $211,000
Q2 2018

Aug 14, 2018

BUY
$13.95 - $32.65 $179,494 - $420,107
12,867 New
12,867 $399,000
Q1 2018

May 15, 2018

SELL
$14.35 - $16.5 $241,438 - $277,612
-16,825 Closed
0 $0
Q4 2017

Feb 27, 2019

SELL
$12.45 - $17.4 $2,689 - $3,758
-216 Reduced 1.27%
16,825 $264,000
Q4 2017

Nov 21, 2018

BUY
$12.45 - $17.4 $2,689 - $3,758
216 Added 1.28%
17,041 $264,000
Q4 2017

Feb 14, 2018

BUY
$12.45 - $17.4 $209,471 - $292,755
16,825
16,825 $261,000

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.28B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Ibex Investors LLC Portfolio

Follow Ibex Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ibex Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ibex Investors LLC with notifications on news.